2021-08-31 11:20
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 31 August 2021 and the following resolutions were passed by the meeting. ADOPTION OF THE INCOME STATEMENT AND BALANCE SHEET The annual...
2021-08-31 08:00
Significant events during the first quarter Significant events after the end of the period Audiocast: When: 2 September 2021 at 10:00 AM CET Where: https://tv.streamfabriken.com/biovica-international-q1-2021-2022 Phone numbers: SE: +46850558365, DK: +4578150108...
2021-08-27 14:30
Biovica, active in cancer diagnostics, today announced that a pre-recorded presentation with CEO Anders Rylander has been published. The Annual General Meeting of Biovica International AB on 31 August 2021 will take place without physical presence, due...
2021-08-10 08:00
Biovica, active in cancer diagnostics, today announced that Warren Cresswell has been appointed President Americas and will be part of the management team. Warren Cresswell has previously worked in senior management roles for 17 years at the Danish diagnostics...
2021-07-30 11:15
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the annual general meeting on Tuesday 31 August 2021. Information with respect to the coronavirus The Company is mindful of the health...
2021-06-30 08:00
Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website Financials – Biovica Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO...
2021-06-17 08:00
Preparations for the launch of DiviTum®TKa Significant events during the fourth quarter Significant events after the end of the period Audiocast: When: 18 June 2021 at 10.00 CET Where: https://tv.streamfabriken.com/biovica-international-q4-2020-2021...
2021-05-22 14:30
Biovica, active in cancer diagnostics, will host a virtual Capital Markets Day on Wednesday 9 June from 14.00 to 16.30. Biovica is approaching market launch of DiviTum®TKa in the US for the monitoring of metastatic breast cancer treatments. Today...
2021-05-20 08:00
May 20, 2021 - Biovica, active in cancer diagnostics, today announces that DiviTumTKa shows prognostic and predictive capabilities in metastatic cutaneous melanoma patients undergoing immunotherapy. These results from a new study at Karolinska University...
2021-04-29 11:00
Biovica, active in cancer diagnostics, today announced that the company has strengthened the management team with Helle Fisker as new commercial manager and Joakim Arwidson as new quality and regulatory manager. Helle Fisker has more than 25 years of...
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects